Fresh Tracks Therapeutics... (FRTX)
NASDAQ: FRTX
· Real-Time Price · USD
0.94
0.00 (0.00%)
At close: Feb 28, 2025, 12:19 PM
Fresh Tracks Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.24M | 2.1M | -2.28M | -4.28M | -4.53M | -6.02M | -1.15M | -9.41M | -6.07M | -13.25M | -11.15M | -9.01M |
Depreciation & Amortization | 10K | 11K | 10K | 10K | 9K | 8K | 6K | 7K | 7K | 7K | 7K | 1K |
Stock-Based Compensation | 267K | 863K | 410K | 379K | 490K | 539K | 576K | 551K | 596K | 777K | 421K | 469K |
Other Working Capital | 40K | -266K | 408K | -64K | 2.31M | 998K | -685K | -2.06M | 336K | 529K | -1.1M | -1.34M |
Other Non-Cash Items | n/a | 17K | 19K | 24K | 15K | 44K | 15K | 14K | 63K | 1.97M | -437K | 3.11M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -15K | -14K | n/a | n/a | n/a | n/a |
Change in Working Capital | -163K | 87K | 29K | -622K | 1.44M | 1.18M | -2.4M | -688K | 603K | -647K | -3.16M | 2.64M |
Operating Cash Flow | -1.12M | 3.08M | -1.82M | -4.49M | -2.58M | -4.25M | -2.97M | -9.54M | -4.8M | -11.14M | -14.31M | -5.89M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -47K | n/a | n/a | n/a | n/a | 4K | -40K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -47K | n/a | n/a | n/a | n/a | 4K | -40K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -28K | -10K | n/a | n/a | 8K | n/a | 29K | -55K | -22K | n/a | n/a | 8.97M |
Financial Cash Flow | -28K | -10K | n/a | 6.57M | 8K | 1.06M | 160K | -55K | 10.3M | 8.12M | 3.94M | 10.6M |
Net Cash Flow | -1.15M | 3.07M | -1.82M | 2.08M | -2.57M | -3.23M | -2.81M | -9.6M | 5.5M | -3.02M | -10.37M | 4.67M |
Free Cash Flow | -1.12M | 3.08M | -1.82M | -4.49M | -2.58M | -4.29M | -2.97M | -9.54M | -4.8M | -11.14M | -14.31M | -5.93M |